In the last trading session, 34,084,786 Geron Corporation (NASDAQ:GERN) shares changed hands as the company’s beta touched 1.1. With the company’s per share price at $1.7 changed hands at -$0.13 or -0.07% during last session, the market valuation stood at $541.57 Million. GERN’s last price was a discount, traded about -38.82% off its 52-week high of $2.36. The share price had its 52-week low at $1.22, which suggests the last value was 28.24% up since then. When we look at Geron Corporation’s average trading volume, we note the 10-day average is 71.95 Million shares, with the 3-month average coming to 7.41 Million.
Analysts gave the Geron Corporation (GERN) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.8. If we narrow down to specifics, the data shows that none out of 4 analysts rate the stock as a Sell, with a further none assigning it an Overweight rating. Of the remaining, none recommended GERN as a Hold, 4 felt it is a Buy and none rated the stock as Underweight. Geron Corporation’s EPS for the current quarter is expected to be -$0.08.
Geron Corporation (NASDAQ:GERN) trade information
Although GERN has turned red as seen at the end of in last trading. With action -7.1%, the performance over the past five days has been green. The jump to weekly highs of $2.23 on Friday, Jun 18 added 23.77% to the stock’s daily price. The company’s shares are showing year-to-date upside of 0.07%, with the 5-day performance at 0.17% in the green. However, in the 30-day time frame, Geron Corporation (NASDAQ:GERN) is 0.19% up. Looking at the short shares, we see there were 26.84 Million shares sold at short interest cover period of 3.62 days.
The consensus price target for the stock as assigned by Wall Street analysts is $4.25, meaning bulls need an upside of 150% from its current market value. According to analyst projections, GERN’s forecast low is $3 with $7 as the target high. To hit the forecast high, the stock’s price needs a +311.76% upsurge from its current level, while the stock would need to tank 76.47% for it to hit the projected low.
Geron Corporation (GERN) estimates and forecasts
Data shows that the Geron Corporation share is not performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value dive -2.86% over the past 6 months, a -28.57% in annual growth rate that is considerably lower than the industry average of 9.1%. But despite this, analysts have looked to lower expectations by downgrading its fiscal year 2021 revenue estimates. The rating firms predict current quarter revenue for Geron Corporation will drop -33.3%, while the growth in revenue is estimated to hit -50% for the next quarter. Year-over-year growth is forecast to reach 22.5% up from the last financial year.
Consensus estimates given by 4 financial analysts project the company’s revenue in the current quarter to hit an average of $60Million. 4 analysts are of the opinion that Geron Corporation’s revenue for the quarter ending September 01, 2021 will be $60Million. The company’s revenue for the corresponding quarters a year ago was $43Million and $108Million respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 39.5%. The estimates for the next quarter sales put growth at -44.4%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 0%. The 2021 estimates are for Geron Corporation earnings to increase by 22.7%, but the outlook for the next 5-year period is at 5% per year.
Geron Corporation (NASDAQ:GERN)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.17% of Geron Corporation shares while 46.23% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 46.31%. There are 207 institutions holding the Geron Corporation stock share, with RA Capital Management, L.P. the top institutional holder. As of Mar 30, 2021, the company held 9.46% of the shares, roughly 30.13 Million GERN shares worth $47.6 Million.
Blackrock Inc. holds the second largest percentage of outstanding shares, with 8.31% or 26.48 Million shares worth $41.84 Million as of Mar 30, 2021.
Among Mutual Funds, the top two as of Apr 29, 2021 were SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF and Vanguard Total Stock Market Index Fund. With 11944119 shares estimated at $17.32 Million under it, the former controlled 3.75% of total outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held about 2.79% of the shares, roughly 8.89 Million shares worth around $14.04 Million.